PLUS1
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
|
|
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
|
|
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
$88.69
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Glaxosmithkline | GSK | London | Ordinary Share | GB0009252882 | ORD 25P |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 5.00 | 0.32% | 1,555.00 | 1,557.80 | 1,536.80 | 1,544.00 | 1,550.00 | 11:29:58 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1,554.80 | 1,555.40 | 0.60 | 0.04% | - | 1 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,348 | 21,378,043 | 1,549.46p | 331,243,284p | - | 1,408.80 - 1,648.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:45:21 | O | 67,049 | 1,555.00p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Glaxosmithkline Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| 77.2Bp | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | -p | 0.00% | - | - |
Glaxosmithkline News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/17/2019 | 09:22 | Alliance News |  Australian Units Of Glaxo And Novartis Admit Misleading.. |
| 5/16/2019 | 06:40 | Dow Jones News | Thermo Fisher to Buy Ireland API Plant From GlaxoSmithKline |
| 5/13/2019 | 12:44 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Block listing Interim Review |
| 5/08/2019 | 13:23 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Result of AGM & GM |
| 5/02/2019 | 12:59 | Dow Jones News | GlaxoSmithKline, Innoviva Asthma Inhaler Meets Primary.. |
| 5/02/2019 | 12:24 | Alliance News | Glaxo Says Phase Three Study Of Trelegy Ellipta Meets.. |
| 5/02/2019 | 12:07 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Trelegy Ellipta asthma study met primary.. |
Glaxosmithkline Discussion Forums - GSK
| Date | Time | Comments | Title |
|---|---|---|---|
| 12/19/2018 | 04:42 | - | Yep 39 now with 5% divvy I don''t |
| 12/19/2018 | 04:18 | - | GSK, PFE form consumer-health JV: #msg-145552190. |
| 12/19/2018 | 04:10 | - | I agree with your theory completely make total sense. |
| 6/13/2018 | 03:33 | - | Novartis'' Entresto is nothing more than an attempt |
| 3/04/2018 | 09:40 | - | Buy anything below 36 not much down side risk. |
| 2/08/2018 | 10:04 | - | Copy of Presentation: |
| 2/07/2018 | 07:50 | - | GSK 4Q17 CC slides: |
| 10/23/2017 | 05:30 | - | https://seekingalpha.com/article/4115400-glaxosmithkline-lands-big-win-shingles- |
| 9/13/2017 | 07:32 | - | [b]Mymetics to Present New Preclinical Data on Thermostable |
| 8/11/2017 | 05:08 | - | Breakthrough in vaccine delivery will disrupt the vaccine |
Historical GSK Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 1,520.8 | 1,557.8 | 1,495.4 | 1,524.1318 | 5M | 21M | 6M | 34.2 | 2.25% |
| 1 Month | 1,524 | 1,598 | 1,495.4 | 1,542.0900 | 5M | 21M | 7M | 31 | 2.03% |
| 3 Months | 1,522 | 1,609.2 | 1,485.2 | 1,541.6370 | 5M | 29M | 8M | 33 | 2.17% |
| 6 Months | 1,559.6 | 1,648.8 | 1,408.8 | 1,523.7564 | 3M | 32M | 9M | -4.6 | -0.29% |
| 1 Year | 1,478.8 | 1,648.8 | 1,408.8 | 1,529.8346 | 3M | 32M | 9M | 76.2 | 5.15% |
| 3 Years | 1,459 | 1,735.5 | 1,236.4 | 1,519.0047 | 736k | 34M | 9M | 96 | 6.58% |
| 5 Years | 1,643.5 | 1,735.5 | 1,227.5 | 1,483.4480 | 371k | 34M | 9M | -88.5 | -5.38% |
